|
20 Dec 2019 |
Agenus Commences Combination Trial of its Next-Gen CTLA-4 with its PD-1 Antibody
|
|
20 Dec 2019 |
InxMed Receives Approval to Initiate Phase I Clinical Trial in China for IN10018
|
|
20 Dec 2019 |
VistaGen and Baylor College of Medicine Announce Successful Results of First-Step Target Engagement Study with VistaGen's AV-101 Focused on Treating Suicidal Ideation in Veterans
|
|
20 Dec 2019 |
AlzeCure Initiates Clinical Trial With ACD856
|
|
20 Dec 2019 |
REGENXBIO Announces Interim Data from Phase I/II Trial of RGX-121 for the Treatment of Mucopolysaccharidosis Type II (MPS II)
|
|
20 Dec 2019 |
GSK announces positive headline results in phase 3 study of Benlysta in patients with lupus nephritis
|
|
20 Dec 2019 |
AbbVie Receives European Commission Approval of RINVOQ™ (upadacitinib) for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis
|
|
20 Dec 2019 |
PharmaMar and Jazz Pharmaceuticals Sign Exclusive License Agreement for Lurbinectedin in the U.S.
|
|
20 Dec 2019 |
Amgen And Allergan Submit Biologics License Application For ABP 798, Biosimilar Candidate To Rituxan® (rituximab), To U.S. Food And Drug Administration
|
|
20 Dec 2019 |
First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response
|
|
20 Dec 2019 |
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-176, an EGFR TKI for NSCLC
|
|
20 Dec 2019 |
Follica Announces Positive Topline Data from Clinical Study in Male Androgenetic Alopecia
|
|
20 Dec 2019 |
Gilead Submits Filgotinib New Drug Application to U.S. Food and Drug Administration Under Priority Review for Rheumatoid Arthritis Treatment
|
|
20 Dec 2019 |
Poxel and Sumitomo Dainippon Pharma Announce Positive Topline Phase 3 Results from TIMES 2 Trial of Imeglimin for the Treatment of Type 2 Diabetes in Japan and Successful Completion of the Pivotal TIMES Clinical Development Program
|
|
20 Dec 2019 |
Galderma receives a positive outcome through the European Decentralised Procedure for AKLIEF® (trifarotene 50 mcg/g cream), the first new retinoid molecule for acne in the European Union in 25 years1
|
|
20 Dec 2019 |
MODAG Initiates First-in-Human Phase 1 Clinical Trial for Anle138b
|
|
20 Dec 2019 |
Zentalis Pharmaceuticals Announces FDA Clearance of the IND for Its Third Oncology Drug Candidate, ZN-c3, a WEE1 Inhibitor, and the Dosing of the First Patient in a Phase 1/2 Clinical Trial
|
|
20 Dec 2019 |
Seattle Genetics Announces U.S. FDA Grants Breakthrough Therapy Designation for Tucatinib in Locally Advanced or Metastatic HER2-Positive Breast Cancer
|
|
20 Dec 2019 |
NeuClone Completes Dosing in Phase I Clinical Trial of Stelara® (ustekinumab) Biosimilar Candidate
|
|
20 Dec 2019 |
Eleusis Announces Phase 1 Trial Results of Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers, Potential to Evaluate as Disease Modifying Therapy for Alzheimer’s Disease
|
